Skip to content

Dosage for dexmedetomidine in spinal anaesthesia

Comparison of 3 Different Dexmedetomidine Doses and Their Effect on the Duration of Spinal Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034532
Enrollment
90
Registered
2021-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: 8- Other Procedures

Interventions

Intervention1: Intrathecal dexmedetomidine three different doses with hyperbaric Bupivacaine: Thirty patients per group were randomly allocated using sealed envelope technique into three groups namely

Sponsors

Shri Ram Murti Smarak Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Ninety patients belonging to ASA physical status I/II, aged 18-60 years of either sex, undergoing elective lower abdominal and lower limb surgeries under planned Subarachnoid Block (SAB).

Exclusion criteria

Exclusion criteria: Exclusion criteria included patient refusal, contraindication to SAB, hypersensitivity to the drugs being evaluated, Body Mass Index (BMI) more than 40 kg/m2, pregnancy, significant comorbid conditions like uncontrolled hypertension, congestive heart failure, myocardial infarction in the past 6 months, heart block, fixed cardiac output lesions. Cases that needed intraoperative conversion to general anesthesia were also excluded.

Design outcomes

Primary

MeasureTime frame
The primary objective was to ascertain a safe IT dexmedetomidine dose for patients undergoing elective lower abdominal and lower limb surgeries and to analyze sensory and motor characteristics with drug combinations being evaluated by comparing duration of the spinal sensory blockade, onset of the sensory and motor blockadeTimepoint: Onset of sensory blockade shall be defined as the time taken from the drug injection to the time to reach T10 level and the offset of sensory block shall be presumed when pin prick sensation at S1 dermatome has returned. Duration of sensory block will be defined as the time interval elapsed between onset of sensory block at T10 to regression of sensory block to S1.

Secondary

MeasureTime frame
Secondary outcome measures included level of sedation, comparison of hemodynamic variables and complications, if any.Timepoint: HR, NIBP(systolic , diastolic and mean NIBP) ,SpO2 will be monitored continuously during the course of surgery and data will be recorded at 5 minutes interval for first 20 minutes then at 15 minutes interval till end of first hour, then at 30 minutes interval for next one hour, hourly for further 2 hours, followed by 4 hourly till completion of 24 hrs

Countries

India

Contacts

Public ContactDr Ashita Mowar

Shri Ram Murti Smarak Institute of Medical Sciences

drash.royals@gmail.com9568578724

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026